ArticleEClinicalMedicine2024

Efficacy and safety of adrenomedullin for acute ischemic stroke (AMFIS): a phase 2, randomized, double-blinded, placebo-controlled, clinical trial.

Takeshi Yoshimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.